During development of the heart, mitochondria proliferate within cardiomyocytes. It is unclear whether this is a response to the increasing energy demand or whether it is part of the developmental program. To investigate the role of the electron transport chain (ETC) in this process, we used transgenic murine embryonic stem (ES) cells in which the green fluorescent protein gene is under control of the α-myosin heavy chain promoter (α-MHC), allowing easy monitoring of cardiomyocyte differentiation. Spontaneous contraction of these cells within embryoid bodies (EBs) was not affected by inhibition of the ETC, suggesting that early heart cell function is sufficiently supported by anaerobic ATP production. However, heart cell development was completely blocked when adding antimycin A, an inhibitor of ETC complex III, before initiation of differentiation, whereas KCN did not block differentiation, strongly suggesting that specifically complex III function rather than mitochondrial ATP production is necessary for early heart cell development. When the underlying mechanism was examined, we noticed that antimycin A but not KCN lead to inhibition of spontaneous intracellular Ca ++ oscillations, whereas both substances decreased mitochondrial membrane potential, as expected. We postulate that mitochondrial complex III activity is necessary for these Ca ++ oscillations, which in turn are a prerequisite for cardiomyocyte differentiation.
representing an essential step for differentiation. To study the role of mitochondria in cardiac development, we used the in vitro differentiation system of murine embryonic stem (ES) cells within embryoid bodies (EB) (2) . ES cells in which the expression of the enhanced green fluorescent protein gene (EGFP) is under control of the α-myosin heavy chain promoter (α-MHC) were used to label ES cell-derived cardiomyocytes (Kolossov et al., unpublished results). Upon development into EBs, cardiomyocyte differentiation can be easily monitored as the appearance of areas of bright green fluorescent cells, which spontaneously contract. Specific inhibitors were used to study the requirement for different complexes of the mitochondrial electron transport chain (ETC) for differentiation. Because Ca ++ seems to play an important role in cardiomyocyte development and mitochondria are involved in Ca ++ -handling, changes in the intracellular Ca ++ concentration and the mitochondrial membrane potential were also measured upon ETC inhibition in heart muscle cells isolated from staged mouse embryos.
Using the specific inhibitor of ETC complex III, antimycin A, our results show that the function of this complex, but not others, is essential for cardiac development, which is not due to the wellknown function of the ETC in ATP synthesis. Rather, the underlying cause appears to be the specific blocking of oscillations of cytosolic Ca ++ by complex III inhibition.
MATERIALS AND METHODS

Cultivation of ES cells and differentiation into embryoid bodies
The ES cell line D3 was used throughout the study (3) . ES cells engineered to express EGFP under control of the α-myosin heavy chain promoter (α-MHC; Kolossov et al., unpublished results) were differentiated into spontaneously beating cardiomyocytes within EBs as described previously (4) . The principle of differentiation is as follows: 1) the cultivation of a definite number of cells (400) in "hanging drops" for 2 days, 2) cultivation of EBs in suspension in bacteriological dishes for a further 5 days, 3) plating of "7 day" EBs into 24-well plates. About 10% of "7 day" EBs already contained first contracting heart cells. In outgrowths of EBs (from 7+1 day onward), they appeared as spontaneously contracting cell clusters. The clusters increased in size during further differentiation.
Study design, observation of EGFP, and contractile activity
In most experiments, drugs were added to EBs after day 2, that is, at the time when they were transferred from hanging drop into suspension culture. Hence, the incubation time with inhibitors was 5 days in suspension culture plus various days in individual wells (7 + x days). Drugs were added in the following concentrations: KCN (1 mM), TTFA (10 µM), antimycin A (50 nM); media were changed every day. To transiently increase intracellular Ca ++ concentration, ionomycin (100 nM) was applied for 2 h to "4 day" or "5 day" EBs, that is, after 2 or 3 days in suspension culture, respectively. EBs were scanned for the presence of EGFP-expressing cells by visual inspection using fluorescence microscopy. In the figures, each panel is representative for at least 12 individual EBs that had been inspected. When the rate of beating was counted, "7+2 day" EBs were used and counting was performed over a period of three further days; averaged values (beats/min) are presented. To compensate for the loss of ETC function in energy metabolism and pyrimidine nucleotide synthesis, we added pyruvate (1 mM) and uridine (50 µg/ml) to all incubations beginning at day 2, irrespective of whether inhibitors were present or not (5) .
Mouse cardiomyocyte preparation, mitochondrial membrane potential, and Ca
2+ measurements
Murine embryonic cardiomyocytes (day E9.5-E18.5) were obtained from superovulated mice of the strain HIM:OF1 (see also ref 6) . Cells were loaded with the cell-permeable Ca 2+ indicator Fura 2-AM or the mitochondrial potential sensitive dye tetramethylrhodamine ethyl ester (TMRE) by incubation in extracellular solution containing 2 µmol/l Fura 2-AM and/or 2 µmol/l TMRE (both from Molecular Probes, Eugene, OR) for 12 min at 37°C. Then cells were washed with extracellular solution and allowed to equilibrate for 5 min.
Cytosolic Ca 2+ and mitochondrial membrane potential was determined by using a monochromator on the excitation side and a 40× oil immersion objective (Zeiss, Jena, Germany), a 510 nm longpass filter, and a cooled CCD camera-based system on the emission side attached to an inverted Zeiss Axiovert microscope (TILL Phototonics,, Planegg, Germany). All recordings were made in 2 × 2 binning mode. For determination of cytosolic Ca 2+ , Fura 2-loaded cells were excited at 340 nm and 380 nm (10 ms, 20 Hz). Ratios of marked cells were calculated offline with subtraction of background intensities at both wavelengths for each frame individually. The data are displayed as 340/380 ratios.
For qualitative determination of the mitochondrial membrane potential TMRE-loaded cells were excited at 485 nm (10 ms, 10 Hz). Depolarization of mitochondria leads to a release of mitochondrial membrane-bound TMRE and therefore to increased fluorescence intensities (unquenching) (7).
The standard extracellular solution contained (in mM): NaCl 137, KCl 5.4, CaCl 2 3.6, MgCl 2 1, HEPES 10, glucose 10, pH 7.4 (adjusted with NaOH). Graphs were generated with Origin 6.0 (OriginLab Corp., Northampton, MA).
Collection of fetal mouse heart tissues
Total hearts were obtained from staged murine fetuses and a 1-month-old mouse expressing EGFP under the control of the α-actin promoter and divided into atria and ventricles. Tissue extracts were prepared in lysis buffer containing 20 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES, pH 7.9), 250 mM NaCl, 0.25% Nonidet P-40, 0.5 mM phenylmethylsulfonyl fluoride, 0.5 mM sodium orthovanadate, 10 mM NaF, and 1 mM dithiothreitol. Tissues were extracted for 10 min at 4°C and centrifuged at 15000 × g for 10 min to remove cell debris.
Western blots
For Western blot analysis, proteins were separated by (SDS)-PAGE and electroblotted onto a polyvinylidene difluoride membrane and then incubated with antibodies as described previously (8) . Antibodies against proteins of interest were obtained from: subunits I and IV of cytochrome c oxidase (Molecular Probes), cytochrome c (BD PharMingen, Palo Alto, CA), and PGC-1α (Chemicon, Temecula, CA). The antiserum against mouse mitochondrial transcription factor A (TFAM) was a generous gift of Prof. David Clayton (Howard Hughes Medical Institute, Chevy Chase, MD). After incubation with primary antibodies, immunoreactive complexes were detected after incubation with secondary peroxidase-labeled antibodies and enhanced chemiluminescence (Perkin Elmer Life Sciences, Boston, MA).
Semiquantitative RT-PCR
The abundance of mRNAs encoding key transcription factors involved in cardiomyocyte differentiation was analyzed by RT-PCR using RNA extracted from 12-24 individual EBs in each group by TRIZOL according to the manufacturer's instructions (Invitrogen, Karlsruhe, Germany). Primers for MEF2C, GATA4, Nkx2.5, and β-tubulin were used as previously described (9) . Reactions were carried out with 200 ng of total RNA using an RT-PCR kit (Invitrogen), yielding single PCR products of the predicted lengths.
RESULTS
To confirm whether mitochondrial activity indeed increases during cardiac development, as reported before for bovine and human heart (1, 10), murine embryos were collected from embryonic day E11.5 to E19.5, and heart tissues were analyzed and compared with adult heart by Western blotting (Fig. 1) . We measured the mitochondrial ETC components cytochrome c oxidase subunit I, encoded by mitochondrial DNA, and cytochrome c oxidase subunit IV and cytochrome c, both encoded by nuclear chromosomes, as well as the coactivator PGC-1α, probably coordinating expression of nuclear encoded mitochondrial genes (11) and TFAM regulating mtDNA expression and copy number (12) (13) . Because heart cells divide in the fetal phase in contrast to the adult stage, and undergo dramatic phenotypic changes, we decided to show an unspecific band reacting with the TFAM antiserum as a loading control instead of a cytoskeletal protein usually used for this purpose (Fig. 1 ). In the atrium, mitochondrial proteins increased between E17.5 and E19.5, and there was another marked rise when comparing E19.5 to adult atrium. In the ventricle, no significant differences were seen in samples between E16.5 and the adult stage for the cytochrome c oxidase subunits, but a notable increase was found for cytochrome c between E19.5 and the adult stage. The transcriptional coactivator PGC-1α and the mitochondrial transcription and replication regulator TFAM increased markedly when adult and late embryonic atria and ventricles were compared.
Cardiomyocytes were unequivocally identified within EBs by their contractile behavior and by the expression of EGFP under control of the α-MHC promoter. Surprisingly, addition of KCN, a potent inhibitor of ETC complex IV, or antimycin A, a specific blocker of ETC complex III, to "7+2 day" EBs containing spontaneously beating heart cells did not block contractile activity of the beating areas during the observation period (Table 1) , nor did it reduce the number of EGFP expressing cells (not shown). In both control and KCN-treated groups, beating rate approximately doubled within the observation period, whereas this increase was blunted by antimycin A. The effectiveness of the substances was proven by showing complete and rapid inhibition of oxygen consumption in HeLa cells using the same stock solutions and concentrations (not shown). Thus, although EBs are well oxygenated, even in their core region (14) , ATP production by oxidative mitochondrial metabolism is obviously neither necessary for the contractile function of early cardiomyocytes, nor for the maintenance of their differentiation stage.
When TTFA, a specific blocker of ETC complex II (Fig. 2B) or KCN ( Fig. 2C ) were applied to "2 day" EBs, directly upon transfer to suspension culture, cardiomyocytes developed into normally appearing, spontaneously beating areas, like under control conditions ( Fig. 2A) . However, surprisingly, no heart cells were detectable when antimycin A was added at this early time point (Fig. 2D) . Thus, normal function of complex III of the ETC seems to be essential for cardiomyocyte differentiation, whereas activity of complexes II and IV, respectively, appears to be dispensable. The effect was completely reversible in case antimycin A was removed after 7+5 days of incubation (Fig. 3A, lower panel) ; in this experiment, heart cells reappeared during cultivation for 10 further days, while no cells were observed if the inhibitor remained present (Fig. 3A, upper panel) . Cultivation of EBs for a total time of 7+7 days in the presence of antimycin A showed that removal of the blocker at the last day of the experimental period was sufficient to enable the appearance of some EGFP-expressing cardiomyocytes (Fig. 3B, bottom  panel) . Thus, the block of differentiation is not due to a general toxicity of antimycin A, but presumably due to interference with some specific signal(s) starting the cardiomyocyte differentiation program. Also, this result shows that precursors are obviously kept in a state of competence for heart cell differentiation in the presence of antimycin A, and immediately start again the differentiation program when the block is removed. To more closely define the exact time point during the course of the developmental program at which complex III activity is essential, antimycin A was applied at different days after transfer into suspension culture (Fig.  3C) . The results clearly demonstrate that cardiomyocyte precursors have passed the critical stage within 2+4 days. If antimycin A was applied before day 4 in suspension culture, differentiation into heart cells was never observed (Fig. 3C, left, middle panel) . However, when it was applied at later stages (Fig. 3C, other panels) , it could not block cardiomyocyte differentiation and beating areas developed normally.
To exclude the possibility that the absence of EGFP-expressing, contracting cells was due to the interference of antimycin A with the formation of EGFP protein and/or the excitation-contraction apparatus, and not due to a true blockade of the cardiomyocyte differentiation program, synthesis of endogenous cardiomyocyte marker proteins was analyzed (Fig. 4) . Western blots of total EB protein extracts show that α-MHC as well as cardiac troponin I, but also EGFP protein were present upon treatment of cells with TTFA, the complex II inhibitor, but not antimycin A. Atrial tissue from a mouse expressing the EGFP protein was also loaded. Therefore, indeed it is the activation of the early cardiac differentiation program that is blocked by complex III inhibition. Note that for these analyses, EB extracts were used because it is difficult to isolate sufficient material of a pure cardiomyocyte fraction, which make up only ~3-5% of the total EB. Thus the signals for cardiac proteins where rather faint, but clearly visible, if present. In contrast to heart cell proteins, the smooth muscle actin isoform was expressed in EBs from all experimental groups (Fig. 4) , demonstrating that blockade of differentiation by antimycin A was specific for cardiomyocytes, but not for smooth muscle cells, another mesodermal derivate. These data also unequivocally prove that the observed effects are not due to a general toxicity of the compound.
A rise in cytosolic Ca ++ has been shown to be important for cardiomyocyte differentiation in EBs (9) , and mitochondria have been demonstrated to be involved in autonomic Ca ++ spiking in neonatal rat heart cells (15) . Thus, we analyzed cytosolic Ca ++ using isolated cardiomyocytes from staged mouse embryos. As depicted in Figure 5A , antimycin A completely blocked the typical rhythmic Ca ++ spiking, while small oscillations were maintained (n=5). On the other hand, KCN had no obvious effect on Ca ++ spikes (Fig. 5B) , spiking rates were 2.12 ± 0.55 Hz under control conditions and 2.15 ± 0.41 Hz during KCN incubation (n=5). During the observation period of such experiments, the effect of antimycin A was irreversible, probably due to rather slow washout of the inhibitor. It should be noted that we used in our experiments antimycin A in concentrations ~20-fold lower than usually employed by others studying the role of mitochondrial Ca ++ handling (e.g., see ref 16) , in order to exclude side effects of the blocker as much as possible. As expected, both antimycin A (n=10) and KCN (n=17) depolarized the inner mitochondrial membrane to about the same extent, however less than the protonophore CCCP (n=2) (Fig. 5C) . The slow decrease of TMRE fluorescence upon antimycin A incubation, which even persisted after removal of the inhibitor from the bath, is probably due to damage of the dye, maybe by increased production of small amounts of reactive oxygen species (ROS; 17). It is obviously not due to a true recovery of the membrane potential, because a second pulse of KCN could not increase TMRE fluorescence again (data not shown). In conclusion, complex III of the ETC seems to be essential for Ca ++ spiking, whereas activity of complex IV appears to be dispensable.
ES cells deficient for the sarcoplasmic reticulum protein calreticulin (crt−/−) showed a severe defect in Ca ++ spiking, and consequently cardiomyocyte differentiation was impaired in EBs from such cells (9), but could be rescued by incubation with the Ca ++ ionophore ionomycin. Therefore, EBs were incubated with ionomycin (100 nM) for 2 h in the presence of antimycin A at selected days and cultivated further until 7+2 days (Fig. 6 ). While antimycin A again blocked the differentiation of cardiomyocytes (Fig. 6, bottom panel) , a single pulse of ionomycin at day 4, that is, 2 days after transfer from hanging drop into suspension culture, but not at day 5, could induce the appearance of significant numbers of heart cells. Thus, indeed it seems to be the blockade of Ca ++ spiking by antimycin A (Fig. 5 ) that is responsible for the differentiation block, which can be replaced by a single Ca ++ pulse, if given at the appropriate stage of differentiation.
Cardiomyocyte differentiation is controlled by a number of transcription factors and coactivators (recently reviewed in ref 18
); therefore, expression of key molecules was analyzed by semiquantitative RT-PCR. Because absolute contents of these mRNAs differ considerably, samples from RT-PCR reactions were collected from 28-36 cycles every second cycle and run on agarose gels. For each mRNA, a cycle was chosen for analysis and is presented in Figure 7 in which the PCR products were well detectable but their concentration still increased in later cycles. RNA from adult mouse heart and ES cells was used as positive and negative controls, respectively. The mRNA for β-tubulin was amplified as a reference and showed that equal amounts of RNA had been introduced into the reactions from all EB preparations (Fig. 7, upper  panel) . PCR products for transcription factors MEF2C, GATA4, and Nkx2.5 could be amplified from mouse heart, but not from ES cells, and the abundance of mRNAs for MEF2C and Nkx2.5, but not for GATA4, increased when "4 day" EBs are compared with "7 day" EBs. However, although antimycin A tended to reduce the concentration of all three mRNAs compared with the appropriate controls, it is obvious that no large differences were observed between treated and untreated EBs. Thus, the blockade of cardiomyocyte differentiation by antimycin A and its rescue by ionomycin are probably not due to large changes in the expression of those key transcription factors.
DISCUSSION
In the present study, we show that a functioning complex III of the mitochondrial ETC is necessary for early heart muscle cell development, which is not due to its role in oxidative metabolism, and thus ATP generation, as one may have expected. During development of the heart, mitochondrial enzyme activities and proteins increase in the bovine and human heart (1, 10) . And, as we also demonstrate here by Western blot analysis of key components of the mitochondrial ETC in the mouse, this occurs mainly at late embryonic stages and again in the postnatal period, that is, when other mitochondrial enzymes like those involved in fatty acid catabolism are induced (19) . Thus, an increased requirement for mitochondrial activity seems to occur only late during fetal heart development and, more importantly, between fetal and adult life. The transcription activators PGC-1α and TFAM are obviously involved in stimulating expression of nuclear encoded mitochondrial genes and mtDNA, respectively, during this process. Mitochondrial proteins are obviously synthesized in a well-coordinated fashion with myofibrillar proteins and other major cell components, which is probably the main reason why not more impressive changes are seen on Western blots, where mitochondrial proteins per total cell protein are measured.
However, it was shown before that mitochondrial function is absolutely necessary for cardiomyogenesis at very early stages. Complete ablation of the ETC in mice through early inactivation of the gene for TFAM completely inhibited heart development (12). TFAM is necessary for transcription and replication of mtDNA (13, 20) , which encodes a few, but essential, protein subunits of complex I, III, IV, and V of the oxidative phosphorylation system (21) . Homozygous tfam −/− animals showed severe growth retardation and died in utero between E8.5 and E10.5 and notably, recognizable cardiac structures were completely absent (12) . Heterozygous animals showed reduced levels of TFAM and mtDNA in all tissues investigated, an obvious gene dosage effect, but only in heart mitochondrial transcript levels, and proteins encoded on mtDNA were significantly reduced. This is probably due to the relatively low copy number of mtDNA (22) compared with the high oxidative capacity of the heart (23). Stage-and cardiac-specific inactivation of the loxP-flanked tfam-gene using cre-recombinase driven by the α-MHC chain promoter, which becomes active in the embryo at E8, or the muscle-specific creatine kinase promoter, active at E13, both lead to severe cardiomyopathy in the adults, and onset of the disease correlated with the different times when mitochondrial biogenesis started to be impaired (24, 25) .
The most obvious explanation for these and our findings may be that ATP production by anaerobic pathways is insufficient to maintain organ function, even in the very early embryo, thus not allowing normal development. However, the absence of cardiac structures in vivo in the tfam −/− embryos (12) already precluded the findings in our present work using an in vitro differentiation system, namely that mitochondrial ETC activity is necessary for heart development but independent of its role in energy generation. Even more interesting, it is not the ETC activity in general, but complex III function, that is a prerequisite for cardiomyocyte differentiation, whereas complexes II and IV are dispensable. Complex III transfers electrons from ubiquinol to cytochrome c, from where they are transferred to molecular oxygen by complex IV (cytochrome c oxidase). Ubiquinone accepts electrons from NADH via complex I during oxidation of acetyl CoA and from FADH2 via complex II during oxidation of fatty acids and succinate. Complex III is also one of the the major sites of superoxide radical formation by one-electron transfer to molecular oxygen, thus ROS formation upon antimycin A treatment could be detrimental to developing heart cells (17) . However, in our hands, using fluorescent dyes and flow cytometry, incubation of HeLa cells with antimycin A in comparable concentrations elicits only very small increases in ROS (26) . In addition, our group has shown previously that endogenous ROS production is necessary and exogenously added H 2 O 2 is even stimulating for cardiomyocyte development in EBs (27) . However, in this study, the possible role of NADPH-oxidase-like enzyme(s) and the downstream involvement of phosphatidylinisitol 3-kinase (PI-3-kinase) was approached by using the inhibitor diphenyleneiodonium. Thus, still one possible explanation for the antimycin A (present study) vs. NAPH-oxidase inhibitor effects (27) would be that ROS derived from different intracellular sources (mitochondrium vs. cytosol/plasma membrane) may have different effects on downstream signaling cascades that are responsible for differentiation.
Another possible explanation for the specific requirement for a functioning complex III is to prevent the build up of a highly reduced ubiquinol pool, which may inhibit the adequate synthesis of pyrimidine-nucleotides for DNA and RNA synthesis via dihydroorotatedehydrogenase, although the precursor uridine was provided in our experiments. During blockade of complex II by TTFA the flow of electrons from complex I to oxygen may still take place, and during blockade of complex IV, alternative electron acceptors such as fumarate could maintain a minimal ETC activity (28) for catalyzing this important reaction. Indeed, recently it was shown that the lack of ubiquinone following ablation of the murine homologue of the C. elegans clk-1 gene leads to embryonic lethality around E9.5, but without largely affecting mitochondrial respiratory activity (29) . Thus, complex III of the mitochondrial ETC indeed seems to have function(s) in development, which are clearly separatable from ATP generation.
Previously, it has been shown that blockade of mitochondrial activity by inhibition of mitochondrial protein synthesis (chloramphenicol), uncoupling of the inner membrane potential from ATP synthesis (CCCP) and inhibition of mitochondrial ATP production (oligomycin) inhibits differentiation of skeletal muscle cells from myoblast precursors (30) . This was also not due to toxicity of these compounds or a decrease of cellular ATP, but rather through specific signaling to the muscle differentiation program via the myogenin gene (31) . Less is known about the cis-regulatory elements and trans-acting factors governing the differentiation of heart muscle cells, however the transcription factor myocyte enhancer factor MEF2C, the zinc-finger protein GATA4 and the coactivator Nkx2.5, among others, are known to be important for early cardiogenesis (18) . Interestingly, it has been shown that absence of Ca ++ spiking in early ES cell derived heart cells lacking the Ca ++ handling protein calreticulin leads to failure of translocation of MEF2C into the nucleus, which is a Ca ++ -calmodulin-kinase dependent process, leading to a severe block of cardiac differentiation. Expression of the above mentioned transcription factors however was unchanged in (crt −/−) compared with wild-type ES cell-derived EBs. A normal cardiomyocyte phenotype could be rescued by a two hours treatment with ionomycin in such crt −/− cell derived EBs, which triggers a transient increase of the cytosolic Ca ++ concentration for about five hours. In addition, the developmental block could be mimicked by chelating Ca ++ in wild-type heart cells (9) . Intriguingly, these authors using the same differentiation protocol as we used here showed that cardiomyocytes seemed to undergo a normal commitment up to 4 days after transfer from hanging drop to suspension culture, but then obviously needed a Ca ++ signal to achieve full differentiation. Mitochondria have been demonstrated to interact with the endoplasmic/sarcoplasmic reticulum during Ca ++ spiking in neonatal rat heart cells involving also IP3-sensitive, internal Ca ++ release sites (15) . We found in the present study that 1) early cardiomyocytes were sensitive to antimycin A also only up to day 2+4, 2) antimycin A inhibited Ca ++ spiking in early heart cells, and 3) the antimycin A block also could be relieved by a ionomycin pulse at day 4. Therefore, we suggest that it is complex III of the mitochondrial ETC that is necessary for autonomous Ca ++ spiking, together with the endoplasmic/sarcoplasmic reticulum. A rise in cytosolic Ca ++ , on the other hand, is indispensable for committing precursor cells to the cardiac differentiation program via Ca ++ -calmodulin-kinase-dependent phosphorylation of MEF2C, which is then translocated into the nucleus. Because antimycin A has no effect on fully differentiated EBs, in contrast to isolated early mouse heart cells, we postulate that the pacemakers of beating areas are insensitive to complex III inhibition. 
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